SEAL Advisors working in partnership with Oberon Capital is pleased to announce the publication of a briefing note on the MyHealthChecked plc. The Future of Personal Health Care Agile and responsive leadership has delivered a competitive array of MyHealthChecked branded COVID-19 testing products in a very short period of time Over the past 12 months the company has been transformed from loss making and cash consumptive, to a high-growth, cash generative business On the basis of reported H1 revenues and Q3 guidance we expect the company to achieve full year 2021 revenues of £15 million and EBITDA of £1.9 million Seizing the opportunities of the pandemic has laid the foundations for MHC to follow its strategy of becoming a leader in the at-home health and wellness testing market MHC is now ideally placed to roll out its range of testing kits focused on weight management, vitamin deficiency, food intolerance, heart health and blood glucose MHC’s strategy is simple and achievable. They have the expertise, the ambition, and the financial strength to become a leading company in the sector The report has been sponsored by MHC and does not constitute independent investment research under FCA Handbook rules. No investment activity in MHC's securities is being invited or induced by the publication of this report. For more information see: www.sealadvisors.com Contact: research@sealadvisors.com SEAL Advisors (a trading name of Scott Evans Associates Ltd) is an appointed representative of Messels Ltd which is authorised and regulated by the Financial Conduct Authority